NCT00701662 arm group 05ee1fc2839f45d824eb9f745c40f6b9 [clinicaltrials_resource:NCT00701662/arm-group/05ee1fc2839f45d824eb9f745c40f6b9]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00701662 arm group 05ee1fc2839f45d824eb9f745c40f6b9 [clinicaltrials_resource:NCT00701662/arm-group/05ee1fc2839f45d824eb9f745c40f6b9]
Bio2RDF identifier
NCT00701662/arm-group/05ee1fc2839f45d824eb9f745c40f6b9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ee1fc2839f45d824eb9f745c40f6b9
description [clinicaltrials_vocabulary:description]
Vivaglobin® is a 16% (160 mg/m ...... .5 g/kg body weight per week).
identifier
clinicaltrials_resource:NCT00701662/arm-group/05ee1fc2839f45d824eb9f745c40f6b9
title
NCT00701662 arm group 05ee1fc2839f45d824eb9f745c40f6b9
@en
type
label
NCT00701662 arm group 05ee1fc2 ...... e1fc2839f45d824eb9f745c40f6b9]
@en